Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Alnylam Pharmaceuticals, Inc. Graphic](https://lunarcrush.com/gi/w:26/t:alnylam-pharmaceuticals-inc.png) Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals (ALNY) stock is experiencing a breakout with positive sentiment, despite an FDA crackdown and ad pull. Truist Securities sees a strong sector rebound and raises ALNY's price target to $XXX.

### About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on RNA interference (RNAi) therapeutics.  
Alnylam Pharmaceuticals, Inc. uses the ticker $ALNY for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/alnylam-pharmaceuticals-inc/insights)
- Alnylam Pharmaceuticals, Inc. (ALNY) trading volume is up XXXXXX% from the previous week.
- Alnylam Pharmaceuticals, Inc. (ALNY) social dominance is up XXXXXX% from the previous week.
- Alnylam Pharmaceuticals, Inc. (ALNY) posts created is up XXXXX% from the previous week.
- Alnylam Pharmaceuticals, Inc. Price hit a 52-Week high of XXXXXX for the hour
- Alnylam Pharmaceuticals, Inc. Price hit an all time of XXXXXX for the hour

### Price: $XXXXXX [#](/topic/alnylam-pharmaceuticals-inc/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/close.tsv)  
The stock price is experiencing volatility due to mixed news. Positive data from the HELIOS-B study and strong sales are countered by the ad pull and negative sentiment on X, leading to a balanced outlook. The 24-hour price change is 0.1%, while the 7-day change is 0.9%, and the 30-day change is -1.17%.  

| 24-Hour | 7-Day | 30-Day |
| ------- | ----- | ------ |
| XXXX%   | XXX%  | XXX%   |

**1-Year High**: $XXXXXX on 2025-09-09  
**1-Year Low**: $XXXXXX on 2025-04-08  
  
  
### AltRank: XXXXX [#](/topic/alnylam-pharmaceuticals-inc/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/alt_rank.tsv)  
Alnylam Pharmaceuticals, Inc. (ALNY) is currently AltRank #1,719 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX -XXX  
**1 Month**: XXXXX +149  
**6 Months**: XXXXX +1,373  
**1 Year**: XXXXX +1,518  
**1-Year High**: XXXXX on 2025-06-26  
**1-Year Low**: X on 2025-03-22  
  
  
### Galaxy Score: XXXXX [#](/topic/alnylam-pharmaceuticals-inc/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX -XX  
**1 Month**: XX +2  
**6 Months**: XX +16  
**1 Year**: XX +3  
**1-Year High**: XX on 2025-02-19  
**1-Year Low**: XX on 2025-06-26  
  
  
### Engagements: XXXXXX [#](/topic/alnylam-pharmaceuticals-inc/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/interactions.tsv)  
**Current Value**: XXXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXX -XX%  
**1 Month**: XXXXXXX -XX%  
**6 Months**: XXXXXXXXX +27%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXXX on 2025-03-21  
**1-Year Low**: XXX on 2025-10-18  

| Social Network | X      | News |
| -------------- | -      | ---- |
| Engagements    | XXXXXX | XX   |
  

  
  
### Mentions: XXX [#](/topic/alnylam-pharmaceuticals-inc/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX +8.40%  
**1 Year**: XXXXX -XXXX%  
**1-Year High**: XXX on 2024-11-28  
**1-Year Low**: XX on 2025-01-27  

| Social Network | X   | News |
| -------------- | -   | ---- |
| Mentions       | XXX | X    |
  

  
  
### Creators: XX [#](/topic/alnylam-pharmaceuticals-inc/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Alnylam Pharmaceuticals, Inc. (ALNY) in the last XX hours which is up XX% from XX in the previous XX hours
**Daily Average**: XXX  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX +83%  
**1 Year**: XXXXX +69%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: XX on 2025-01-27  

The most influential creators that mention Alnylam Pharmaceuticals, Inc. in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@semodough](/creator/twitter/semodough)             | X    | XXXXXX    | X     | XXXXX       |
| [@Biobeats99](/creator/twitter/Biobeats99)           | X    | XXX       | XX    | XXXXX       |
| [@wallstengine](/creator/twitter/wallstengine)       | X    | XXXXXX    | X     | XXX         |
| [@RNAiAnalyst](/creator/twitter/RNAiAnalyst)         | X    | XXXXXX    | X     | XXX         |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)     | X    | XXXXX     | X     | XXX         |
| [@Quantumup1](/creator/twitter/Quantumup1)           | X    | XXXXX     | X     | XXX         |
| [@occams_tooth](/creator/twitter/occams_tooth)       | X    | XXX       | X     | XXX         |
| [@Specialpstock](/creator/twitter/Specialpstock)     | X    | XXX       | X     | XXX         |
| [@boogeymantradez](/creator/twitter/boogeymantradez) | X    | XXXXX     | X     | XXX         |
| [@GeneInvesting](/creator/twitter/GeneInvesting)     | XX   | XXXXXX    | X     | XXX         |

[View More](/list/creators/alnylam-pharmaceuticals-inc/100)
  
  
### Sentiment: XX% [#](/topic/alnylam-pharmaceuticals-inc/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% +34%  
**6 Months**: XX% +29%  
**1 Year**: XX% +12%  
**1-Year High**: XXX% on 2025-07-29  
**1-Year Low**: XX% on 2025-05-28  

**Most Supportive Themes**
- **Positive Data from HELIOS-B Study:** (35%) New data from the HELIOS-B Phase X study demonstrates lower rates of gastrointestinal events in ATTR-CM patients treated with Vutrisiran, supporting its role as a first-line therapy.
- **Amvuttra Sales and Revenue Guidance:** (20%) Alnylam reported strong Amvuttra sales and raised its 2025 revenue guidance, indicating positive financial performance.
- **First Patient Dosed in ZENITH Trial:** (15%) Alnylam announced the first patient dosed in the ZENITH Global Phase X cardiovascular outcomes trial of Zilebesiran, signaling progress in its clinical pipeline.
  
**Most Critical Themes**
- **FDA Crackdown and Ad Pull:** (10%)  Alnylam pulled TV ads following a crackdown on drug industry advertising, which may raise concerns.
- **Negative Sentiment on X:** (20%)  A large percentage of X posts express negative sentiment, with many users expressing concerns about the company.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
| News    | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
  

  
  
### Social Dominance: XXXXX% [#](/topic/alnylam-pharmaceuticals-inc/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/social_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXX% +0.0087%  
**1 Month**: XXXXX% +0.012%  
**6 Months**: XXXXX% +0.0013%  
**1 Year**: XXXXX% -XXXXX%  
**1-Year High**: XXXXX% on 2024-11-06  
**1-Year Low**: XXXXXX% on 2025-07-29  
  
  
### Market Dominance: XXXXX% [#](/topic/alnylam-pharmaceuticals-inc/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2025-09-09  
**1-Year Low**: XXXXX% on 2025-01-06  
  
  
### Market Cap: $XXXXXXXXXXXXXX [#](/topic/alnylam-pharmaceuticals-inc/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXXX +$5.30%  
**1 Month**: $XXXXXXXXXXXXXX +$6.60%  
**6 Months**: $XXXXXXXXXXXXXX +$108%  
**1 Year**: $XXXXXXXXXXXXXX +$66%  
**1-Year High**: $XXXXXXXXXXXXXX on 2025-09-09  
**1-Year Low**: $XXXXXXXXXXXXXX on 2025-04-08  

**Top assets mentioned**
In the posts about Alnylam Pharmaceuticals, Inc. in the last XX hours

[Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny)
[BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Intellia Therapeutics, Inc (NTLA)](/topic/$ntla)
[BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn)
[Johnson & Johnson (JNJ)](/topic/johnson-johnson)
[Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions)
[Arrowhead Research Corporation (ARWR)](/topic/$arwr)
[Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl)

**Top topics mentioned**
In the posts about Alnylam Pharmaceuticals, Inc. in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$bbio](/topic/$bbio), [stocks technology](/topic/stocks-technology), [$pfe](/topic/$pfe), [investment](/topic/investment), [stocks financial services](/topic/stocks-financial-services), [$ntla](/topic/$ntla), [stocks](/topic/stocks), [coins defi](/topic/coins-defi), [coins base ecosystem](/topic/coins-base-ecosystem), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$bmrn](/topic/$bmrn), [johnson johnson](/topic/johnson-johnson), [coins dao](/topic/coins-dao), [$ions](/topic/$ions), [$arwr](/topic/$arwr), [telegram](/topic/telegram), [stocks industrials](/topic/stocks-industrials), [stocks consumer defensive](/topic/stocks-consumer-defensive), [stocks banks](/topic/stocks-banks), [$mdgl](/topic/$mdgl), [$jnj](/topic/$jnj), [$qure](/topic/$qure), [$mrk](/topic/$mrk), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$orcl](/topic/$orcl), [$insm](/topic/$insm), [$adhcon](/topic/$adhcon), [stocks basic materials](/topic/stocks-basic-materials), [iii](/topic/iii), [bloomberg](/topic/bloomberg), [stocks utilities](/topic/stocks-utilities), [has been](/topic/has-been), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [bitmine](/topic/bitmine), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [$atyr](/topic/$atyr), [neurocrine biosciences inc](/topic/neurocrine-biosciences-inc), [$sln](/topic/$sln), [$dnli](/topic/$dnli), [$imvt](/topic/$imvt), [$amgn](/topic/$amgn), [$ge](/topic/$ge), [stocks defense](/topic/stocks-defense), [albemarle corp](/topic/albemarle-corp), [$alb](/topic/$alb), [allegion plc](/topic/allegion-plc), [crowdstrike](/topic/crowdstrike), [$ahr](/topic/$ahr), [$alab](/topic/$alab), [reit](/topic/reit), [$eqix](/topic/$eqix), [sanofi](/topic/sanofi), [$ecl](/topic/$ecl), [$ferg](/topic/$ferg), [$incy](/topic/$incy), [$tr](/topic/$tr), [$aeis](/topic/$aeis), [gilead sciences](/topic/gilead-sciences), [$prqr](/topic/$prqr), [stocks energy](/topic/stocks-energy), [coins bsc](/topic/coins-bsc), [$dy](/topic/$dy), [$cien](/topic/$cien), [coins solana ecosystem](/topic/coins-solana-ecosystem), [nasdaq](/topic/nasdaq), [samuel](/topic/samuel), [sofi technologies](/topic/sofi-technologies), [alt aptoslaunch token](/topic/alt-aptoslaunch-token), [$alnys](/topic/$alnys), [biogen inc](/topic/biogen-inc), [$regn](/topic/$regn), [$eypt](/topic/$eypt), [$ocul](/topic/$ocul), [$rna](/topic/$rna), [$vrt](/topic/$vrt), [$rvmd](/topic/$rvmd), [$alks](/topic/$alks), [mcdonalds corp](/topic/mcdonalds-corp), [$xene](/topic/$xene), [$nvo](/topic/$nvo), [illumina inc](/topic/illumina-inc), [$ilmn](/topic/$ilmn), [$alsn](/topic/$alsn), [agilent technologies inc](/topic/agilent-technologies-inc), [applovin](/topic/applovin), [$kymr](/topic/$kymr), [$nvs](/topic/$nvs), [$tln](/topic/$tln), [$rytm](/topic/$rytm), [rna](/topic/rna), [stockmarket](/topic/stockmarket), [$ajg](/topic/$ajg), [$wfc](/topic/$wfc), [align technology inc](/topic/align-technology-inc), [$algn](/topic/$algn), [$abbv](/topic/$abbv), [money](/topic/money), [$92b](/topic/$92b), [$adhcfda](/topic/$adhcfda)

### Top Social Posts [#](/topic/alnylam-pharmaceuticals-inc/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Stock Market Streak Tracker UP: $ALNY - X days Up $MCD - X days Up $CVS - X days Up DOWN: $LNG - X days Down $FICO - X days Down $TRP - X days Down Streak Tracker"  
[X Link](https://x.com/TimedTrades/status/1979279460747641335) [@TimedTrades](/creator/x/TimedTrades) 2025-10-17T20:12Z XX followers, XX engagements


"stocks that hit new XX WEEK HIGHS today (Oct 17): $GILD Gilead Sciences $CVS $MNST Monster Beverage $ALNY Alnylam $COR Cencora $EL Estee Lauder $SNDK Sandisk $BG Bunge $ROIV Roivant $WTRG Essential Utilities $ENSG Ensign Group $IDCC InterDigital $FIGS $TR Tootsie Roll Industries $NKTR Nektar $PBPB Potbelly $AEIS Advanced Energy Industries $IRON Disc Medicine"  
[X Link](https://x.com/HKWealthLab/status/1979271535920660745) [@HKWealthLab](/creator/x/HKWealthLab) 2025-10-17T19:41Z 1802 followers, XXX engagements


"$AHR -Citizens JMP raises American Healthcare REIT target to $XX from $XX Market Outperform - $ALAB -Stifel raises Astera Labs target to $XXX from $XXX Buy - $ALNY -Truist raises Alnylam Pharmaceuticals target to $XXX from $XXX Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/1979225948622065737) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-10-17T16:40Z 7574 followers, XXX engagements


"🐳whale selling $3.9m $ALNY XXX C 12/19/2025"  
[X Link](https://x.com/FlowbyBobby/status/1979223332278145312) [@FlowbyBobby](/creator/x/FlowbyBobby) 2025-10-17T16:29Z 2911 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Alnylam Pharmaceuticals, Inc. Graphic Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals (ALNY) stock is experiencing a breakout with positive sentiment, despite an FDA crackdown and ad pull. Truist Securities sees a strong sector rebound and raises ALNY's price target to $XXX.

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on RNA interference (RNAi) therapeutics.
Alnylam Pharmaceuticals, Inc. uses the ticker $ALNY for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

  • Alnylam Pharmaceuticals, Inc. (ALNY) trading volume is up XXXXXX% from the previous week.
  • Alnylam Pharmaceuticals, Inc. (ALNY) social dominance is up XXXXXX% from the previous week.
  • Alnylam Pharmaceuticals, Inc. (ALNY) posts created is up XXXXX% from the previous week.
  • Alnylam Pharmaceuticals, Inc. Price hit a 52-Week high of XXXXXX for the hour
  • Alnylam Pharmaceuticals, Inc. Price hit an all time of XXXXXX for the hour

Price: $XXXXXX #


Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price is experiencing volatility due to mixed news. Positive data from the HELIOS-B study and strong sales are countered by the ad pull and negative sentiment on X, leading to a balanced outlook. The 24-hour price change is 0.1%, while the 7-day change is 0.9%, and the 30-day change is -1.17%.

24-Hour 7-Day 30-Day
XXXX% XXX% XXX%

1-Year High: $XXXXXX on 2025-09-09
1-Year Low: $XXXXXX on 2025-04-08

AltRank: XXXXX #


AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Alnylam Pharmaceuticals, Inc. (ALNY) is currently AltRank #1,719 based on combined combined social and market metrics Daily Average: XXX
1 Week: XXX -XXX
1 Month: XXXXX +149
6 Months: XXXXX +1,373
1 Year: XXXXX +1,518
1-Year High: XXXXX on 2025-06-26
1-Year Low: X on 2025-03-22

Galaxy Score: XXXXX #


Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -XX
1 Month: XX +2
6 Months: XX +16
1 Year: XX +3
1-Year High: XX on 2025-02-19
1-Year Low: XX on 2025-06-26

Engagements: XXXXXX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX +27%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-03-21
1-Year Low: XXX on 2025-10-18

Social Network X News
Engagements XXXXXX XX

Mentions: XXX #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Month: XXX -XX%
6 Months: XXXXX +8.40%
1 Year: XXXXX -XXXX%
1-Year High: XXX on 2024-11-28
1-Year Low: XX on 2025-01-27

Social Network X News
Mentions XXX X

Creators: XX #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Alnylam Pharmaceuticals, Inc. (ALNY) in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XXX
1 Month: XXX -XX%
6 Months: XXXXX +83%
1 Year: XXXXX +69%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-01-27

The most influential creators that mention Alnylam Pharmaceuticals, Inc. in the last XX hours

Creator Rank Followers Posts Engagements
@semodough X XXXXXX X XXXXX
@Biobeats99 X XXX XX XXXXX
@wallstengine X XXXXXX X XXX
@RNAiAnalyst X XXXXXX X XXX
@MarcJacksonLA X XXXXX X XXX
@Quantumup1 X XXXXX X XXX
@occams_tooth X XXX X XXX
@Specialpstock X XXX X XXX
@boogeymantradez X XXXXX X XXX
@GeneInvesting XX XXXXXX X XXX

View More

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% +34%
6 Months: XX% +29%
1 Year: XX% +12%
1-Year High: XXX% on 2025-07-29
1-Year Low: XX% on 2025-05-28

Most Supportive Themes

  • Positive Data from HELIOS-B Study: (35%) New data from the HELIOS-B Phase X study demonstrates lower rates of gastrointestinal events in ATTR-CM patients treated with Vutrisiran, supporting its role as a first-line therapy.
  • Amvuttra Sales and Revenue Guidance: (20%) Alnylam reported strong Amvuttra sales and raised its 2025 revenue guidance, indicating positive financial performance.
  • First Patient Dosed in ZENITH Trial: (15%) Alnylam announced the first patient dosed in the ZENITH Global Phase X cardiovascular outcomes trial of Zilebesiran, signaling progress in its clinical pipeline.

Most Critical Themes

  • FDA Crackdown and Ad Pull: (10%) Alnylam pulled TV ads following a crackdown on drug industry advertising, which may raise concerns.
  • Negative Sentiment on X: (20%) A large percentage of X posts express negative sentiment, with many users expressing concerns about the company.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXXXX XX% XXX X%
News X X% X X% X X%
Total XXXXX XX% XXXXX XX% XXX X%

Social Dominance: XXXXX% #


Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.0087%
1 Month: XXXXX% +0.012%
6 Months: XXXXX% +0.0013%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2024-11-06
1-Year Low: XXXXXX% on 2025-07-29

Market Dominance: XXXXX% #


Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-09-09
1-Year Low: XXXXX% on 2025-01-06

Market Cap: $XXXXXXXXXXXXXX #


Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXX +$5.30%
1 Month: $XXXXXXXXXXXXXX +$6.60%
6 Months: $XXXXXXXXXXXXXX +$108%
1 Year: $XXXXXXXXXXXXXX +$66%
1-Year High: $XXXXXXXXXXXXXX on 2025-09-09
1-Year Low: $XXXXXXXXXXXXXX on 2025-04-08

Top assets mentioned In the posts about Alnylam Pharmaceuticals, Inc. in the last XX hours

Alnylam Pharmaceuticals, Inc. (ALNY) BridgeBio Pharma, Inc. Common Stock (BBIO) Pfizer, Inc. (PFE) Intellia Therapeutics, Inc (NTLA) BioMarin Pharmaceutical, Inc. (BMRN) Johnson & Johnson (JNJ) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Arrowhead Research Corporation (ARWR) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)

Top topics mentioned In the posts about Alnylam Pharmaceuticals, Inc. in the last XX hours

stocks healthcare, $bbio, stocks technology, $pfe, investment, stocks financial services, $ntla, stocks, coins defi, coins base ecosystem, stocks consumer cyclical, $bmrn, johnson johnson, coins dao, $ions, $arwr, telegram, stocks industrials, stocks consumer defensive, stocks banks, $mdgl, $jnj, $qure, $mrk, regeneron pharmaceuticals inc, $orcl, $insm, $adhcon, stocks basic materials, iii, bloomberg, stocks utilities, has been, stocks bitcoin treasuries, bitmine, stocks crypto treasuries, $atyr, neurocrine biosciences inc, $sln, $dnli, $imvt, $amgn, $ge, stocks defense, albemarle corp, $alb, allegion plc, crowdstrike, $ahr, $alab, reit, $eqix, sanofi, $ecl, $ferg, $incy, $tr, $aeis, gilead sciences, $prqr, stocks energy, coins bsc, $dy, $cien, coins solana ecosystem, nasdaq, samuel, sofi technologies, alt aptoslaunch token, $alnys, biogen inc, $regn, $eypt, $ocul, $rna, $vrt, $rvmd, $alks, mcdonalds corp, $xene, $nvo, illumina inc, $ilmn, $alsn, agilent technologies inc, applovin, $kymr, $nvs, $tln, $rytm, rna, stockmarket, $ajg, $wfc, align technology inc, $algn, $abbv, money, $92b, $adhcfda

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Stock Market Streak Tracker UP: $ALNY - X days Up $MCD - X days Up $CVS - X days Up DOWN: $LNG - X days Down $FICO - X days Down $TRP - X days Down Streak Tracker"
X Link @TimedTrades 2025-10-17T20:12Z XX followers, XX engagements

"stocks that hit new XX WEEK HIGHS today (Oct 17): $GILD Gilead Sciences $CVS $MNST Monster Beverage $ALNY Alnylam $COR Cencora $EL Estee Lauder $SNDK Sandisk $BG Bunge $ROIV Roivant $WTRG Essential Utilities $ENSG Ensign Group $IDCC InterDigital $FIGS $TR Tootsie Roll Industries $NKTR Nektar $PBPB Potbelly $AEIS Advanced Energy Industries $IRON Disc Medicine"
X Link @HKWealthLab 2025-10-17T19:41Z 1802 followers, XXX engagements

"$AHR -Citizens JMP raises American Healthcare REIT target to $XX from $XX Market Outperform - $ALAB -Stifel raises Astera Labs target to $XXX from $XXX Buy - $ALNY -Truist raises Alnylam Pharmaceuticals target to $XXX from $XXX Buy -"
X Link @MarcJacksonLA 2025-10-17T16:40Z 7574 followers, XXX engagements

"🐳whale selling $3.9m $ALNY XXX C 12/19/2025"
X Link @FlowbyBobby 2025-10-17T16:29Z 2911 followers, XXX engagements

Alnylam Pharmaceuticals, Inc. (ALNY)
/topic/alnylam-pharmaceuticals-inc